Altergon competitive analysis

Explore Altergon's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Apr 24, 2024Hybrid Cooperative Complexes Of Hyaluronic Acid1
Aug 30, 2023Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T41
Jun 28, 2023Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic Cystitis1
Jul 22, 2020High-Stability Packaged Solutions Of T4 Thyroid Hormone1

Latest PTAB cases involving Altergon

Discover the latest PTAB cases involving Altergon, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Altergon with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALTERGON - 4 - -
FIDIA FARMACEUTICI12 - -
STREHLKE6 - - -
UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A.4 - - -